4 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18739149 | NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS | MCINTOSH III, TRAVISS C | 1693 | Final Rejection | Jun 10, 2024 |
| 18540608 | ADVANTAGEOUS ANTI-HCV COMBINATION THERAPY | LEWIS, PATRICK T | 1691 | Non-Final OA | Dec 14, 2023 |
| 18111316 | STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES | PIHONAK, SARAH | 1627 | Non-Final OA | Feb 17, 2023 |
| 17971318 | STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES | WILLIS, DOUGLAS M | 1624 | Non-Final OA | Oct 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial